How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

  • Question on Consultation

    Do you agree with the proposal not to update the guideline (yes/no)? Please also provide any supporting comments you wish to make

  • Question on Consultation

    Do you have any comments on areas excluded from the scope of the guideline (yes/no)? If so, please provide any supporting comments you wish to make

  • Question on Consultation

    Do you have any comments on equalities issues (yes/no)? If so, please provide any supporting comments you wish to make
The content on this page is not current guidance and is only for the purposes of the consultation process.

2019 surveillance of intravenous fluid therapy in children and young people in hospital (2015) NICE guideline NG29 – summary of evidence

Closed for comments This consultation ended on at   Request commenting lead permission

Research recommendations

What is the incidence of complications during, and as a consequence of, IV fluid therapy in children and young people?

  • No new evidence relevant to the research recommendation was found and no ongoing studies were identified.

What is the most appropriate glucose concentration in IV fluids for children and young people of different ages?

  • The new evidence found no difference in hyperglycaemia with 0.3% sodium chloride in 3.3% dextrose versus 0.9% sodium chloride in 5% dextrose for post-operative fluid maintenance and is unlikely to affect the guideline.

For children and young people receiving IV fluids, does the use of a standardised national fluid balance chart reduce the rate of complications arising as a result of prescription and/or administration errors?

  • No new evidence relevant to the research recommendation was found and no ongoing studies were identified.

Does ensuring that all hospital healthcare professionals involved in prescribing and delivering IV fluids for children and young people are appropriately trained in the principles of fluid prescribing and IV fluid therapy-related complications lead to a reduction in IV fluid-related complications and associated healthcare costs?

  • No new evidence relevant to the research recommendation was found and no ongoing studies were identified.